Skip to content
by Legal Desire
4 June 2026

DLA Piper advises on Star Sports Medicine’s Hong Kong IPO and H share listing

Advising firms

Deal team

11 lawyers named
LawyerFirmSeniorityPracticeOffice
George Wu Lead DLA Piper Partner Equity Capital Markets Hong Kong
Sherlyn Lau DLA Piper Partner Capital Markets and Corporate Finance Hong Kong
Evonne Zhong DLA Piper Other Not stated Hong Kong
Marcus Ng DLA Piper Associate Not stated Hong Kong
Maki Han DLA Piper Other Not stated Hong Kong
Dillon Tsang DLA Piper Trainee Not stated Hong Kong
Jack Du DLA Piper Other Not stated Shanghai
Zihan Wu DLA Piper Other Not stated Shanghai
Zayn Jiang DLA Piper Other Not stated Beijing
Johnson Yang Shanghai Kaiman Law Firm Other Not stated Shanghai
Kate Shen Shanghai Kaiman Law Firm Other Not stated Shanghai

8 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
HKD 830m (HKD830 million)
What the figure measures
Issue size
Client
Not stated
Counterparties
Star Sports Medicine Co., Ltd. (Issuer)
CITIC Securities (Hong Kong) Limited (Underwriters)
CCB International Capital Limited (Underwriters)